22.86USD-3.46%Mkt Cap: 2.24B USDP/E: —Last update: 2026-06-01
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in N…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.24B USD
Enterprise Value3.14B USD
Revenue (TTM)670.00M USD
Gross Profit564.00M USD
Net Income (TTM)-575.00M USD
Revenue/Share6.722 USD
Last Price22.86 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.4K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)24.80
PEG—
EV/EBITDA-6.33
EV/Revenue4.69
P/S3.52
P/B-28.84
EPS (TTM)-6.10
EPS (Forward)0.97
52W Range
18.2919% of range42.37
52W High42.37 USD
52W Low18.29 USD
Profitability
Gross Margin83.80%
Oper. Margin-102.21%
EBITDA Margin-74.18%
Profit Margin-85.44%
ROE718.75%
ROA-37.53%
Growth
Revenue Growth-2.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-466.00M USD
CapEx (TTM)21.00M USD
FCF Margin-32.70%
FCF Yield-9.77%
Net Debt787.00M USD
Net Debt/EBITDA-1.58
Balance Sheet
Debt/Equity-0.45
Current Ratio2.02
Quick Ratio1.65
Book Value/Sh-0.8300 USD
Cash/Share4.206 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Strong Buy)
Target (Mean)52.05 USD
Target Range25.00 USD – 96.00 USD
# Analysts19
Ownership
Shares Out.98.49M
Float94.50M
Insiders3.46%
Institutions104.17%
Short Interest
Short Ratio8.3d
Short % Float14.68%
Short % Out.14.19%
Shares Short13.98M
Short (prev mo.)12.09M
Technical
SMA 5023.43 (-2.4%)
SMA 20027.47 (-16.8%)
Beta0.39
S&P 52W Chg27.70%
Avg Vol (30d)1.50M
Avg Vol (10d)1.45M
Technical Indicators
RSI (14)46.2
MACD-0.2247
MACD Signal0.0310
MACD Hist.-0.2557
BB Upper27.36 USD
BB Middle24.70 USD
BB Lower22.03 USD
BB Width21.61%
ATR (14)1.055 USD
Vol Ratio (20d)0.56x